4/A//SEC Filing
Yaacov-Garbeli Dana 4/A
Accession 0001178913-24-002392
CIK 0001638097other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:31 PM ET
Size
8.5 KB
Accession
0001178913-24-002392
Insider Transaction Report
Form 4/AAmended
Entera Bio Ltd.ENTX
Yaacov-Garbeli Dana
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-04-19+130,000→ 130,000 totalExercise: $1.99Exp: 2034-04-19→ Ordinary Shares, par value NIS 0.0000769 per share (130,000 underlying) - Award
Ordinary Shares, par value NIS 0.0000769 per share
2024-04-19+30,151→ 86,731 total(indirect: By A2Z Counseling Ltd.)
Footnotes (4)
- [F1]Represent a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 19, 2024.
- [F2]On April 23, 2024, the reporting person filed a Form 4 which inadvertently reported that the reporting person's ordinary shares and restricted stock units are held directly.
- [F3]These shares are owned by A2Z Counseling Ltd. of which the reporting person owns a 33.33% interest and has effective control over voting and disposition of the shares. The reporting person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F4]The options vest over a three-year period with 33% of the options vesting on April 19, 2025, the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period.
Documents
Issuer
Entera Bio Ltd.
CIK 0001638097
Entity typeother
Related Parties
1- filerCIK 0001909822
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:31 PM ET
- Size
- 8.5 KB